Compare Stocks

Date Range: 

 Burning Rock BiotechVeracyteFulgent GeneticsCareDxGenetron
SymbolNASDAQ:BNRNASDAQ:VCYTNASDAQ:FLGTNASDAQ:CDNANASDAQ:GTH
Price Information
Current Price$27.16$44.35$74.64$77.71$19.66
52 Week RangeBuyBuyHoldBuyBuy
MarketRank™
Overall Score1.11.41.41.00.4
Analysis Score2.53.31.11.51.5
Community Score2.53.02.42.70.6
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.80.00.0
Earnings & Valuation Score0.60.62.50.60.0
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$32.30$64.71$74.40$75.67$19.50
% Upside from Price Target18.92% upside45.92% upside-0.32% downside-2.63% downside-0.81% downside
Trade Information
Market Cap$2.84 billion$2.98 billion$2.16 billion$4.04 billion$1.75 billion
BetaN/A0.771.920.84N/A
Average Volume347,845932,7501,854,764723,088402,245
Sales & Book Value
Annual RevenueN/A$120.37 million$32.53 million$127.07 million$45.68 million
Price / SalesN/A24.7766.5231.8338.25
CashflowN/AN/A$0.15 per shareN/AN/A
Price / CashN/AN/A498.37N/AN/A
Book ValueN/A$4.90 per share$4.42 per share$2.33 per shareN/A
Price / BookN/A9.0516.8933.35
Profitability
Net IncomeN/A$-12,600,000.00$-410,000.00$-21,970,000.00$-95,470,000.00
EPSN/A($0.27)$0.02($0.52)N/A
Trailing P/E Ratio0.00N/A36.95N/A0.00
Forward P/E RatioN/AN/A13.82N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-30.46%35.31%-11.79%N/A
Return on Equity (ROE)N/A-12.27%43.81%-10.95%N/A
Return on Assets (ROA)N/A-10.95%36.82%-7.94%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio9.84%26.60%3.39%4.14%5.74%
Quick Ratio9.59%26.28%3.39%3.98%5.68%
Ownership Information
Institutional Ownership Percentage15.79%N/A33.39%N/A19.56%
Insider Ownership PercentageN/A8.30%45.00%3.10%N/A
Miscellaneous
Employees938320480456799
Shares Outstanding104.55 million67.24 million28.99 million52.05 million88.87 million
Next Earnings Date5/25/2021 (Confirmed)5/10/2021 (Confirmed)8/3/2021 (Estimated)8/3/2021 (Estimated)5/24/2021 (Confirmed)
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable
SourceHeadline
Genetron Holdings Limited (NASDAQ:GTH) Short Interest UpdateGenetron Holdings Limited (NASDAQ:GTH) Short Interest Update
americanbankingnews.com - April 17 at 2:18 AM
Genetron Health Releases 22 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2021Genetron Health Releases 22 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2021
finance.yahoo.com - April 13 at 5:49 AM
Tron – Understanding Genetron Holdings Limited (NASDAQ:GTH)’s Growth PotentialTron – Understanding Genetron Holdings Limited (NASDAQ:GTH)’s Growth Potential
fintechzoom.com - April 10 at 12:50 PM
Genetron Health to Present at the SVB Leerink CybeRx Series: Liquid Biopsy & Oncology Dx SummitGenetron Health to Present at the SVB Leerink CybeRx Series: Liquid Biopsy & Oncology Dx Summit
benzinga.com - April 1 at 6:30 PM
Earnings Update: Heres Why Analysts Just Lifted Their Genetron Holdings Limited (NASDAQ:GTH) Price Target To US$26.22Earnings Update: Here's Why Analysts Just Lifted Their Genetron Holdings Limited (NASDAQ:GTH) Price Target To US$26.22
nasdaq.com - March 27 at 2:35 PM
Genetron Holdings Limited (NASDAQ:GTH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$26.22Genetron Holdings Limited (NASDAQ:GTH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$26.22
finance.yahoo.com - March 27 at 9:35 AM
Genetron Health Releases New Data Results of HCCscreen for Liver Cancer Early Screening in ChinaGenetron Health Releases New Data Results of HCCscreen for Liver Cancer Early Screening in China
financialbuzz.com - March 25 at 7:20 AM
Genetron Health Reports Unaudited Fourth Quarter and Full Year 2020 Financial Results, and Provides 2021 Revenue GuidanceGenetron Health Reports Unaudited Fourth Quarter and Full Year 2020 Financial Results, and Provides 2021 Revenue Guidance
finance.yahoo.com - March 25 at 7:20 AM
Genetron Health Releases New Data Results of HCCscreen™ for Liver Cancer Early Screening in ChinaGenetron Health Releases New Data Results of HCCscreen™ for Liver Cancer Early Screening in China
finance.yahoo.com - March 24 at 7:24 PM
Genetron Health to Participate at Credit Suisse Asian Investment Conference on Mar. 26th, 2021Genetron Health to Participate at Credit Suisse Asian Investment Conference on Mar. 26th, 2021
finance.yahoo.com - March 17 at 6:20 PM
Genetron Health to Announce Fourth Quarter and Full Year 2020 Unaudited Financial Results and Host Investor Call on March 25, 2021Genetron Health to Announce Fourth Quarter and Full Year 2020 Unaudited Financial Results and Host Investor Call on March 25, 2021
finance.yahoo.com - March 4 at 6:59 PM
Bullish or Bearish for Genetron Holdings Limited (NASDAQ:GTH) in 2021Bullish or Bearish for Genetron Holdings Limited (NASDAQ:GTH) in 2021
stocksregister.com - March 1 at 7:00 PM
Genetron Healths Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in ChinaGenetron Health's Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in China
benzinga.com - February 9 at 5:34 PM
Genetron Health’s Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in ChinaGenetron Health’s Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in China
finance.yahoo.com - February 9 at 7:31 AM
Genetron Health to Release Thirteen Research Findings at 21st World Conference on Lung CancerGenetron Health to Release Thirteen Research Findings at 21st World Conference on Lung Cancer
finance.yahoo.com - January 27 at 7:15 AM
Stock Alert: Genetron Holdings Shares Surge 24%Stock Alert: Genetron Holdings Shares Surge 24%
markets.businessinsider.com - January 6 at 12:37 PM
Genetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen(TM) in ChinaGenetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen(TM) in China
stockhouse.com - January 6 at 7:36 AM
Genetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen in ChinaGenetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen in China
wallstreet-online.de - January 6 at 7:36 AM
Genetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen™ in ChinaGenetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen™ in China
finance.yahoo.com - January 6 at 7:36 AM
Do Institutions Own Genetron Holdings Limited (NASDAQ:GTH) Shares?Do Institutions Own Genetron Holdings Limited (NASDAQ:GTH) Shares?
finance.yahoo.com - December 20 at 10:30 AM
Where Do Hedge Funds Stand On Genetron Holdings Limited (GTH)?Where Do Hedge Funds Stand On Genetron Holdings Limited (GTH)?
finance.yahoo.com - December 12 at 12:03 AM
Genetron Health Provides Update on HCCscreen for Liver Cancer Early Screening in ChinaGenetron Health Provides Update on HCCscreen for Liver Cancer Early Screening in China
wallstreet-online.de - November 28 at 11:38 PM
Genetron up 2% after HCCscreen selected by NCC, Wuxi for public health initiative in ChinaGenetron up 2% after HCCscreen selected by NCC, Wuxi for public health initiative in China
seekingalpha.com - November 27 at 3:38 PM
Genetron Health Provides Update on HCCscreen(TM) for Liver Cancer Early Screening in ChinaGenetron Health Provides Update on HCCscreen(TM) for Liver Cancer Early Screening in China
stockhouse.com - November 27 at 10:37 AM
Genetron Says Wuxi Selects HCCscreen For Liver Cancer Screening Project - Quick FactsGenetron Says Wuxi Selects HCCscreen For Liver Cancer Screening Project - Quick Facts
nasdaq.com - November 27 at 10:37 AM
DateCompanyBrokerageAction
7/13/2020Burning Rock BiotechBank of AmericaInitiated Coverage
7/7/2020Burning Rock BiotechMorgan StanleyInitiated Coverage
7/7/2020Burning Rock BiotechCowenInitiated Coverage
4/27/2021VeracyteSVB LeerinkLower Price Target
4/14/2021VeracyteNeedham & Company LLCReiterated Rating
1/27/2021VeracyteTruistInitiated Coverage
12/17/2020VeracyteLake Street CapitalBoost Price Target
12/17/2020VeracyteBTIG ResearchBoost Price Target
11/9/2020VeracyteKeyCorpInitiated Coverage
11/2/2020VeracyteWilliam BlairReiterated Rating
3/11/2021Fulgent GeneticsPiper SandlerBoost Price Target
2/1/2021Fulgent GeneticsOppenheimerBoost Price Target
1/8/2021Fulgent GeneticsCredit Suisse GroupDowngrade
9/25/2020Fulgent GeneticsCSFBBoost Price Target
11/5/2019Fulgent GeneticsPiper Jaffray CompaniesUpgrade
5/6/2021CareDxRaymond JamesLower Price Target
2/26/2021CareDxHC WainwrightDowngrade
1/4/2021CareDxCraig HallumBoost Price Target
8/10/2020CareDxJefferies Financial GroupReiterated Rating
9/30/2020GenetronCanaccord GenuityReiterated Rating
(Data available from 5/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.